Loading
Joinn Laboratories(China)Co.,Ltd. Stock: price and insider trades · China
昭衍新药
No insider purchase over the last 90 days. The latest, by 于爱水, was filed 29 Sept 2021.
Insider Decl.
44
Thresholds
n/a
Buy Volume
€94,205
1 ops. · all time
Sell Volume
€191M
43 ops. · all time
Who traded when
BuySale孙云霞1 sale
Since the insiders bought
- -49.9%Entry CN¥80.61 · Close at T+365 CN¥40.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Joinn Laboratories(China)Co.,Ltd. Buy (bullish), based on 6 analysts. Average price target: CN¥38.79.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,458 of 26,250 companies
54.8
score / 100
Value40
Quality69
FCF yld0.9%
Earn yld0.9%
EV/EBITDA·
ROE12%
Gross mgn21%
Net mgn18%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥45.90
Analyst consensus
6 analystsBuy
CN¥12.60Target CN¥38.79(-15%)CN¥66.84
Income statement
RevenueCN¥1.7B
Gross profitCN¥343.3M21% margin
EBITDACN¥483.2M29% margin
Net incomeCN¥297.8M58.2% margin
Valuation
PER (trailing)37.0x
P/Book3.8x
Beta0.87
Balance sheet & cash
Market capCN¥34.4B
Total debtCN¥21.6M
Free Cash FlowCN¥301M
Debt / Equity0%
Profitability & ownership
ROE11.5%
ROA-0.7%
% insiders40.7%
% institutions16.3%
Last declaration on 30 September 2025
Declarations44 total
20,000 shares6.4% of flowA股XSHGSSE:173000009615288770
4,000 shares5.4% of flowA股XSHGSSE:173000007087307460
3,000 shares4.2% of flowA股XSHGSSE:173000007075373760
199,960 shares54.8% of flowA股XSHGSSE:173000007068789150
148,000 shares38.9% of flowA股XSHGSSE:173000007065879970
489,940 shares3.9% of flowA股XSHGSSE:173000007065879800
1,000,000 shares8.0% of flowA股XSHGSSE:173000007060665860
300,000 shares3.6% of flowA股XSHGSSE:173000006685315140
200,000 shares2.4% of flowA股XSHGSSE:173000006682445340
300,000 shares4.0% of flowA股XSHGSSE:173000006666870560
196,300 shares2.7% of flowA股XSHGSSE:173000006654602560
3,025,954 shares60.3% of flowA股XSHGSSE:173000005913389900
2,141,980 shares23.7% of flowA股XSHGSSE:173000005894076400
10,584 shares100.0% of flowA股XSHGSSE:173000005746690560
2,000 shares12.1% of flowA股XSHGSSE:173000005648954080
4,775,000 shares76.3% of flowA股XSHGSSE:173000005614953250
1,000 shares6.2% of flowA股XSHGSSE:173000005599083140
1,000 shares5.8% of flowA股XSHGSSE:173000005576250560
320,000 shares20.5% of flowA股XSHGSSE:173000005552153250
460,400 shares30.2% of flowA股XSHGSSE:173000005547691360
456,370 shares30.6% of flowA股XSHGSSE:173000005545269540
286,160 shares18.8% of flowA股XSHGSSE:173000005542844740
300,000 shares100.0% of flowA股XSHGSSE:173000005552088300
192,700 shares10.5% of flowA股XSHGSSE:173000005176769470
311,980 shares21.5% of flowA股XSHGSSE:173000004928452030
25 of 44 declarations
About Joinn Laboratories(China)Co.,Ltd.
Joinn Laboratories(China)Co.,Ltd. (昭衍新药), a Chinese health care and pharma company valued at CNY 34.4 billion and 40.7% held by its insiders, offers a record of 44 filings dominated by selling. 43 of them are sales, worth EUR 190.7 million with a median of EUR 1,055,112; a single purchase, EUR 94,205, is reported by 于爱水 (高级管理人员) on September 29, 2021.
The peak is a sale of EUR 68,257,951 by 顾美芳 (董事) on June 23, 2022, followed by EUR 26,138,211 for 左从林 (董事) on September 27, 2022 and EUR 21,254,476 for 顾美芳 on September 6, 2022. 左从林 and 顾晓磊, both 董事, sign 9 filings each, 姚大林 6, and 冯宇霞 like 李叶 (监事) 4. None of these names filed a purchase.
Read moreShow less
The years weigh unevenly: 21 filings in 2021, 12 in 2022, 10 in 2023, then a single one in 2025. Filings run from May 20, 2021 to September 30, 2025, and the last twelve months hold none. The purchase accounts for just 2% of open-market trades.
